The Technical Analyst
Select Language :
Aerie Pharmaceuticals Inc [AERI]

Exchange: NASDAQ Global Market Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Aerie Pharmaceuticals Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Aerie Pharmaceuticals Inc is listed at the NASDAQ Exchange

11.47% $8.36

Last updated: 3 jul 2022 - 20:25

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 406.49 mill
EPS: -1.472
P/E: 0.000
Earnings Date: Aug 02, 2022
SharesOutstanding: 48.62 mill
Avg Daily Volume: 0.652 mill
RATING 2022-07-01
B-
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Neutral
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profit
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$9.16
(9.60%) $0.803
Date: 2022-07-04
True Range Average
+/- $0.569
( +/- 6.81%)
Range: 7.79 - 8.93
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-06-09 Mchugh Julie Buy 16 854 Stock Option (right to buy)
2022-06-09 Mchugh Julie Buy 6 245 Common Stock
2022-06-09 Mcgraw Benjamin F Iii Buy 16 854 Stock Option (right to buy)
2022-06-09 Mcgraw Benjamin F Iii Buy 6 245 Common Stock
2022-06-09 Mcdonnell Peter J Buy 16 854 Stock Option (right to buy)
INSIDER POWER
89.01
Last 100 transactions
Buy: 2 092 921 | Sell: 145 950

Forecast: 16:00 - $8.36

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $8.36
Forecast 2: 16:00 - $8.36
Forecast 3: 16:00 - $8.36
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $8.36 (11.47% )
Volume 0.641 mill
Avg. Vol. 0.652 mill
% of Avg. Vol 98.32 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aerie Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aerie Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Aerie Pharmaceuticals Inc

Last 10 Buy & Sell Signals For AERI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since 31-12-69

Date Signal @ Closed %
Jun 28 - 16:58sell$7.83N/AActive
The Live Chart for Aerie Pharmaceuticals Inc
Profile picture for
            Aerie Pharmaceuticals Inc

AERI

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, dry eye, retinal diseases, and other eye diseases. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma and ocular hypertension. The company is also developing AVX-012, a clinical-stage dry eye product candidate; and AR-1105 and AR-13503 sustained-release implants for treating retinal diseases. Aerie Pharmaceuticals, Inc. has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.

Last 10 Buy Signals
Date Signal @
QRLUSDJul 3 - 20:220.177
NXTUSDJul 3 - 20:220.0034
UBQUSDJul 3 - 20:220.0337
BATUSDJul 3 - 20:210.401
NEOUSDJul 3 - 20:218.30
QTUMUSDJul 3 - 20:212.83
MLNUSDJul 3 - 20:1824.38
BNBUSDJul 3 - 20:18219.48
XMRUSDJul 3 - 20:18116.67
BCHUSDJul 3 - 20:18105.84

Stock Peers

Company Price Change
AERI8.3611.47%
ADGI3.506.71%
AZRX3.452.07%
EWTX8.081.51%
GBIO6.702.13%
LIAN2.285.56%
MCRB3.635.83%
PHAT9.077.46%
SOPH3.733.04%
XERS1.500-2.60%
ZYXI8.071.13%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.